Clinical Trials Browser

Phase 3 × Nasopharyngeal Carcinoma × Radiosurgery × Clear all

NCT04944914 2021-06-30

Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma

Phase 3 Recruiting

Nasopharyngeal Carcinoma